Drugs in phase I and II clinical development for the prevention of stroke in patients with atrial fibrillation-Reference-Cited by-同舟云学术

Drugs in phase I and II clinical development for the prevention of stroke in patients with atrial fibrillation

Published:2021-03-15 Issue:10 Volume:30 Page:1057-1069
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Bentley Robert¹²,Hardy Lewis J.³,Scott Laura J²,Sharma Parveen¹²,Philippou Helen³,Lip Gregory Y. H.¹⁴

Affiliation:

1. Liverpool Centre for Cardiovascular Sciences, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK

2. Department of Cardiovascular & Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK

3. Discovery and Translational Science Department, Faculty of Medicine and Health, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK

4. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2021.1897786

Reference88 articles.

1. Global rising trends of atrial fibrillation: a major public health concern

2. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

3. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study

4. Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation

5. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Comprehensive Review;Cureus;2024-07-25

2. Future of factor XI inhibitors in cardiovascular practice;Minerva Cardiology and Angiology;2024-05

3. Quantitative Systems Pharmacology for Rare Disease Drug Development;Journal of Pharmaceutical Sciences;2023-09

4. The new era of anticoagulation: factor XI and XII inhibitors;Bleeding, Thrombosis, and Vascular Biology;2023-06-07

5. New pharmacotherapeutic options for oral anticoagulant treatment in atrial fibrillation patients aged 65 and older: factor XIa inhibitors and beyond;Expert Opinion on Pharmacotherapy;2023-05-29